Showing results (111-120 of 349) with videos related to
Sort By:
Pageof 35
American Journal of Clinical Pathology|December 1, 1993
The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimensB A Centeno, D N Louis, W J Kupsky, et al.Brain Pathology (Zurich, Switzerland)|July 1, 1997
Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiformeY Hayashi, K Ueki, A Waha, et al.Journal of Neurosurgery|May 1, 1992
The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapyJ Glass, F H Hochberg, M L Gruber, et al.Human Pathology|December 1, 1992
Desmoplastic cerebral astrocytomas of infancy: a histopathologic, immunohistochemical, ultrastructural, and molecular genetic studyD N Louis, A von Deimling, G R Dickersin, et al.Cancer Research|January 1, 1996
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlatedK Ueki, Y Ono, J W Henson, et al.The American Journal of Pathology|July 5, 2001
PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosisH Sasaki, M C Zlatescu, R A Betensky, et al.Acta Neuropathologica|March 2, 2005
Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomasPortia A Kreiger, Yoshifumi Okada, Scott Simon, et al.The American Journal of Surgical Pathology|September 8, 2000
Primary lymphoma of peripheral nerve: report of four casesJ Misdraji, Y Ino, D N Louis, et al.Genes & Development|August 4, 2001
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivoC Dai, J C Celestino, Y Okada, et al.Leukemia|March 23, 1999
Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphomaM B Møller, Y Ino, A M Gerdes, et al.Pageof 35